Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02782806 · ClinicalTrials.gov registry record · NA
Spot-Check Noninvasive Pulse CO-Oximeter Validation
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 368
- Enrollment target
NCT02782806: Completed NA study, sponsored by Masimo Corporation.
NCT02782806 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 368 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02782806, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 368 participants
- Enrollment target
Study Summary
In this study, the accuracy of a noninvasive hemoglobin sensor(s) will be assessed by comparison to hemoglobin measurements from a laboratory analyzer.
Primary Outcome
Accuracy willl be determined by comparing the noninvasive hemoglobin measurement of the pulse oximeter to the hemoglobin value obtained from a blood sample and calculating the arithmetic root mean square(Arms) error value.
Interventions
- DEVICE Masimo Rad-67 Pulse Oximeter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 368 participants |
| Start Date | 2016-04-11 |
| Est. Completion | 2016-05-19 |
| Phase | NA |
What the finished NCT02782806 record still lists
NCT02782806 is an interventional study that assigns participants to a tested intervention. The registered 368 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 1 intervention - of which Masimo Rad-67 Pulse Oximeter is the first listed.
NCT02782806 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02782806 about?
NCT02782806 is a clinical study titled "Spot-Check Noninvasive Pulse CO-Oximeter Validation". In this study, the accuracy of a noninvasive hemoglobin sensor(s) will be assessed by comparison to hemoglobin measurements from a laboratory analyzer.
What is the current status of trial NCT02782806?
This trial is currently completed. It is a NA study. The enrollment target is 368 participants. The study started on 2016-04-11. Estimated completion is 2016-05-19.
What interventions are being tested in trial NCT02782806?
The interventions under investigation include: Masimo Rad-67 Pulse Oximeter (DEVICE).
Who is sponsoring clinical trial NCT02782806?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02782806's enrollment target sits among peer trials
368 283rd of 2000 higher than 1,717 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04675476 · 368 participants · NA
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
- NCT05215353 · 368 participants · Phase 4
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors
- NCT06182397 · 368 participants · NA
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
- NCT06629610 · 368 participants · NA
Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI